Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill

被引:0
|
作者
Benjamin Brenner
Russell Hull
Roopen Arya
Jan Beyer-Westendorf
James Douketis
Ismail Elalamy
Davide Imberti
Zhenguo Zhai
机构
[1] Rambam Health Care Campus,Department of Hematology and Bone Marrow Transplantation
[2] University of Calgary,Foothills Medical Centre and Thrombosis Research Unit
[3] King’s College Hospital NHS Foundation Trust,King’s Thrombosis Centre, Department of Haematological Medicine
[4] University Hospital ‘Carl Gustav Carus’ Dresden,Thrombosis Research Unit, Department of Medicine I, Division Hematology
[5] King’s College London,King’s Thrombosis Service, Department of Haematology
[6] McMaster University,Department of Medicine
[7] Thrombosis and Atherosclerosis Research Institute,Hematology and Thrombosis Center
[8] I.M. Sechenov First Moscow State Medical University,Haemostasis and Thrombosis Center
[9] Tenon University Hospital,Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine
[10] Sorbonne University,undefined
[11] Hospital of Piacenza,undefined
[12] China-Japan Friendship Hospital,undefined
[13] National Clinical Research Center for Respiratory Diseases,undefined
来源
关键词
Venous thromboembolism; Cancer; Critically ill; Anticoagulants; Low-molecular-weight heparin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] CLINICAL EFFECTS OF ORAL MELATONIN IN HIGH-RISK CRITICALLY ILL
    Mistraletti, G.
    Tozzi, M.
    Miori, S.
    Taverna, M.
    Cerri, B.
    Galluccio, I.
    Umbrello, M.
    Salini, S.
    Morabito, A.
    Fraschini, F.
    Iapichino, G.
    INTENSIVE CARE MEDICINE, 2011, 37 : S254 - S254
  • [32] Extended Venous Thromboembolism Prophylaxis for High-Risk Patients Undergoing Surgery for Malignancy
    Perre, A.
    Markman, M.
    CASE REPORTS IN ONCOLOGY, 2011, 4 (01): : 115 - 117
  • [33] Leg Compression and Pharmacologic Prophylaxis for Venous Thromboembolism Prevention in High-Risk Patients
    Meyer, Suzanne
    AMERICAN FAMILY PHYSICIAN, 2010, 81 (03) : 284 - 285
  • [34] Venous thromboembolism prophylaxis in high risk medically ill patients; a meta analysis.
    Kanaan, Abir O.
    Donovan, Jennifer L.
    Silva, Matthew A.
    Roy, Tara
    Al-Homsi, Ahmad-Samer
    BLOOD, 2006, 108 (11) : 262A - 263A
  • [35] Risk factors for venous thromboembolism in critically ill nontrauma surgical patients who cannot receive chemical prophylaxis
    Patel, Madhukar S.
    Ewing, Tyler
    Kong, Allen
    David Nguyen
    Lau, Cecilia
    Barrios, Cristobal
    Cinat, Marianne
    Dolich, Matthew
    Lekawa, Michael
    Malinoski, Darren
    AMERICAN JOURNAL OF SURGERY, 2013, 206 (03): : 300 - 306
  • [36] EFFECTIVENESS OF CLINICAL GUIDELINES FOR DVT PROPHYLAXIS IN REDUCING THE INCIDENCE OF VENOUS THROMBOEMBOLISM IN CRITICALLY ILL CHILDREN AFTER TRAUMA
    Hanson, Sheila
    Punzalan, Rowena
    Arca, Marjorie
    Simpson, Pippa
    Christensen, Melissa
    Braun, Kristen
    Havens, Peter
    CRITICAL CARE MEDICINE, 2010, 38 (12) : U55 - U55
  • [37] An Economic Evaluation of Venous Thromboembolism Prophylaxis Strategies in Critically III Trauma Patients at Risk of Bleeding
    Chiasson, T. Carter
    Manns, Braden J.
    Stelfox, Henry Thomas
    PLOS MEDICINE, 2009, 6 (06)
  • [38] The risk of maternal venous thromboembolism disease. Synopsis and definition of high-risk groups
    Ninet, J
    ANNALES DE MEDECINE INTERNE, 2003, 154 (5-6): : 301 - 309
  • [39] The Use of Betrixaban for Extended Prophylaxis of Venous Thromboembolism Events in Hospitalized, High-Risk Patients
    Dobesh, Paul P.
    Ahuja, Tania
    Davis, George A.
    Fatodu, Hugh
    Francis, William H.
    Hull, Frank P.
    Johnson, Gary L.
    Lenchus, Joshua D.
    Lenoir, Jacqueline Glee
    McPherson, Claudette
    Nemeth, Jeffrey
    Riello, Ralph J., III
    AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (22): : S475 - S482
  • [40] Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline
    Al-Hameed, Fahad
    Al-Dorzi, Hasan M.
    Al Momen, Abdulkarim
    Algahtani, Farjah
    Al Zahrani, Hazzaa
    Al Saleh, Khalid
    Al Sheef, Mohammed
    Owaidah, Tarek
    Alhazzani, Waleed
    Neumann, Ignacio
    Wiercioch, Wojtek
    Brozek, Jan
    Schuenemann, Holger
    Akl, Elie A.
    ANNALS OF SAUDI MEDICINE, 2015, 35 (02) : 95 - 106